Accelerating drug discovery - Although the evolution of '-omics' methodologies is still in its infancy, both the pharmaceutical industry and patients could benefit from their implementation in the drug development process

被引：79

作者：

Kraljevic, S ^{[1
]}

Stambrook, PJ

Pavelic, K

机构：

[1] Rudjer Boskovic Inst, Div Mol Med, Lab Funct Genom, Zagreb, Croatia

[2] Univ Cincinnati, Med Ctr, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA

来源：

EMBO REPORTS | 2004年 / 5卷 / 09期

关键词：

D O I：

10.1038/sj.embor.7400236

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：837 / 842

页数：6

共 31 条

[21] Functional and structural proteomics: a critical appraisal [J].

Lefkovits, I .

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 787 (01) :1-10

[22] Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: Criteria, validation, strategies [J].

Lesko, LJ ;

Atkinson, AJ .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2001, 41 :347-366

[23] Metabonomics and its role in drug development and disease diagnosis [J].

Lindon, JC ;

Holmes, E ;

Nicholson, JK .

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2004, 4 (02) :189-199

[24] Application of proteomics to the study of molecular mechanisms in neurotoxicology [J].

LoPachin, RM ;

Jones, RC ;

Patterson, TA ;

Slikker, W ;

Barber, DS .

NEUROTOXICOLOGY, 2003, 24 (06) :761-775

[25] Gene expression in cancer: the application of microarrays [J].

Macgregor, PF .

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2003, 3 (02) :185-200

[26]

Michelson S, 2000, CURR OPIN MOL THER, V2, P651

[27] The utility of DNA microarrays for characterizing genotoxicity [J].

Newton, RK ;

Aardema, M ;

Aubrecht, J .

ENVIRONMENTAL HEALTH PERSPECTIVES, 2004, 112 (04) :420-422

[28] Characterization of variability in large-scale gene expression data: Implications for study design [J].

Novak, JP ;

Sladek, R ;

Hudson, TJ .

GENOMICS, 2002, 79 (01) :104-113

[29] In vivo toxicity screening programs using metabonomics [J].

Robosky, LC ;

Robertson, DG ;

Baker, JD ;

Rane, S ;

Reily, MD .

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2002, 5 (08) :651-662

[30] An EU perspective on the use of in vitro methods in regulatory pharmaceutical toxicology [J].

Snodin, DJ .

TOXICOLOGY LETTERS, 2002, 127 (1-3) :161-168

← 1 2 3 4 →